Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Intraoperative Nociception and Postoperative Pain
Completed
- Conditions
- Pain, PostoperativeNociceptive PainAnalgesics
- Interventions
- Device: SPI group
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2019-07-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03761433
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT03758729
Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03756233
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot Study
Not Applicable
Completed
- Conditions
- Breast NeoplasmsMammaplastyAcellular Dermis
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT03744273
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
Not Applicable
Completed
- Conditions
- Non-alcoholic Fatty Liver
- Interventions
- Dietary Supplement: TrehaloseOther: Placebo
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 39
- Registration Number
- NCT03738358
Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma
Phase 2
- Conditions
- Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
- Interventions
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 79
- Registration Number
- NCT03730740
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Effect of Robot Gait Training With Brain Stimulation on Gait Function in Stroke Patients
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Device: Robot gait trainingDevice: Brain stimulation
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03708016
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer
Active, not recruiting
- Conditions
- Lung Neoplasms
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1050
- Registration Number
- NCT03705546
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
Phase 2
Completed
- Conditions
- Type2 Diabetes MellitusRenal InsufficiencyAlbuminuria
- Interventions
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 209
- Registration Number
- NCT03667300
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors
Phase 2
- Conditions
- Non-small Cell Lung Cancer Metastatic
- Interventions
- Drug: Placebo plus chemotherapy
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 98
- Registration Number
- NCT03656094
- Locations
- 🇰🇷
Jong-Mu Sun, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath